Employers urged to address stigma and rethink benefits for workers with obesity
Specialty pharma claims triple as pharmacists fill gaps in primary care, TELUS Health report finds
Province reopens review of insurer-pharmacy deals while regulator holds off on decision
Wegovy claims soared 91% in 2024 as insurers weigh coverage limits and rising plan costs
Wegovy drives 91% spike in Canadian drug claims while Zepbound outperforms in US clinical trial
Canadian Drug Insurance Pooling Corporation members saved over $946 million in out-of-pocket drug costs through extended policy plans in 2023
